Chromogranin A Cell Density as a Diagnostic Marker for Lymphocytic Colitis
Lymphocytic colitis (LC) can be mistakenly diagnosed as irritable bowel syndrome (IBS). In a previous study on IBS, some patients showed extremely high colonic chromogranin A cell density. Further examination of these patients showed that they suffered from LC.
To investigate whether chromogranin A cell density is increased in LC patients and to examine the possibility of using this increase as a marker for the diagnosis of LC.
Fifty-seven patients diagnosed with LC and 54 controls were included in the study. Biopsies from the right and left colon were obtained from both patients and controls, which were immunostained using the Avidin–biotin-complex method for chromogranin A, and cell density was quantified.
In both the right and left colon of patients with LC, the density of chromogranin A was significantly higher than in controls. This increase in chromogranin A cells occurs whether the number of these cells is expressed as number/mm2 epithelium or as number/field. Chromogranin A cell density for the right and left colon expressed as number of cells/mm2 epithelium or as cell number/field showed a high sensitivity and specificity as a diagnostic marker for LC.
Chromogranin A is a common marker for endocrine cells, and the present finding suggests that colonic hormones are involved in the pathophysiology of LC. The chromogranin cell density seems to be a good diagnostic marker with high sensitivity and specificity in both the right and left colon, thus sigmoidoscopy can be used in the diagnosis of LC using with this marker.
- Liszka L, Woszczyk D, Pajak J. Histopathological diagnosis of microscopic colitis. J Gastroenterol Hepatol. 2006;21:792–797. CrossRef
- Fernandez-Banares F, Salas A, Forne M, et al. Incidence of collagenous and lymphocytic colitis: a 5-year population-based study. Am J Gastroenterol. 1999;94:418–423.
- Chande N, MacDonald JK, McDonald JW. Interventions for treating microscopic colitis: a Cochrane inflammatory bowel disease and functional bowel disorders review group systematic review of randomized trials. Am J Gastroenterol. 2009;104:235–241. CrossRef
- Pardi DS, Kelly CP. Microscopic colitis. Gastroenterology. 2011;140:1155–1165. CrossRef
- Pardi DS. Microscopic colitis: an update. Inflamm Bowel Dis. 2004;10:860–870. CrossRef
- Yen EF, Pardi DS. Review article: microscopic colitis-lymphocytic, collagenous and mast cell colitis. Allment Pharmacol Ther. 2011;34:21–32. CrossRef
- Agnarsdottir M, Gunnlaugsson O, Orvar KB, et al. Collagenous and lymphocytic colitis in Iceland. Dig Dis Sci. 2002;47:1122–1128. CrossRef
- Fernandez-Banares F, Forne M, Esteve M, et al. Collagenous colitis and lymphocytic colitis in Terrassa, Spain: an epidemilogical Study 1993–1996. Gastroenterology. 1997;122:A15.
- Olesen M, Eriksson S, Bohr J, et al. Microscopic colitis: a common diarrheal disease. An epidemiological study in Örebro, Sweden, 1993–1998. Gut. 1995;37:394–397.
- El-Salhy M, Halwe J, Lomholt-Beck B, Gundersen D. The prevalence of inflammatory bowel diseases and microscopic colitis and colorectal cancer in patients with irritable bowel syndrome. Gastroenterol Insights. 2011;3:7–10. doi:10.4081/gi.2011.e3. CrossRef
- El-Salhy M, Gundersen D, Hatlebakk JG, Hausken T. Irritable bowel syndrome. New York: Nova Science Publisher; 2012.
- El-Salhy M, Lomholt-Beck B, Hausken T. Chromogranin as a tool in the diagnosis of irritable bowel syndrome. Scan J Gastroenterol. 2010;45:1435–1439. CrossRef
- El-Salhy M, Lomholt-Beck B, Gundersen D. High chromgranin A cell density in the colon of patients with lymphocytic colitis. Mol Med Rep. 2011;4:603–605.
- Goya PK. Hirano I mechanisms of disease: the enteric nervous system. N Engl J Med. 1996;334:1106–1615. CrossRef
- McConalouge K, Furness JB. Gastrointestinal neurotransmitters. Baillieres Clin Endocrinol Metab. 1994;8:51–76. CrossRef
- Debas HT, Mulvihill SJ. Neuroendocrine design of the gut. Am J Surg. 1991;161:243–249. CrossRef
- El-Salhy M. Gut neuroendocrine system in diabetes gastroenteropathy: possible role in pathophysiology and clinical implications. In: Ashley M, ed. Focus on Diabetes Research. New York: Nova Science Publisher; 2006:79–102.
- Taupenot L, Harper KL, O’Connor DT. The chromogranin-secretogranin family. N Engl J Med. 2003;348:1134–1149. CrossRef
- Wicdenmann B, Huttner WB. Synaptophysin and chromogranin/secretogranins-widespread constituents of distinct types of neuroendocrine vesicales and new tools in tumor diagnosis. Virchows Arch B Cell Pathol. 1989;58:95–121. CrossRef
- Deftos LJ. Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker. Endocr Rev. 1991;12:181–188. CrossRef
- El-Salhy M, Sandsrøm E, Nästrøm E, et al. Application of computer image analysis in endocrine cell quantification. Histochemical J. 1997;29:249–256. CrossRef
- Khan WI, Ghia JE. Gut hormones: emerging role in immune activation and inflammation. Clin Exp Immunol. 2010;161:19–27.
- Zhang D, Shooshtarizadeh P, Laventie BJ, et al. Two chromogranin a-derived peptides induce calcium entry in human neutrophils by calmodulin-regulated calcium independent phospholipase A2. PLoS ONE. 2009;4:e4501. CrossRef
- Egger M, Beer AG, Theurl L, et al. Monocyte migration: a novel effect and signaling pathway of catestatin. Eur J Pharmacol. 2008;598:104–111. CrossRef
- Feistritzer C, Mosheimer BA, Colleselli D, Wiedermann CI, Kahler CM. Effects of the neuropeptide secretoneurin on natural kill cell migration and cytokine release. Regul Pept. 2005;126:195–201. CrossRef
- Ferrero E, Magni E, Curnis F, Villa A, Ferrro ME, Corti A. Regulation of endothelial cells barrier function by chromogranin A. Ann NY Acad Sci. 2002;971:355–358. CrossRef
- El-Salhy M, Danielsson Å, Stenling R, Grimelius L. Colonic endocrine cells in inflammatory bowel disease. J Int Med. 1997;242:413–419. CrossRef
- Sciola V, Maaironi S, Conte D, et al. Plasmachromogranin A in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:867–871. CrossRef
- Sidhu R, Drew K, Lobo AJ. Elevated serum chromogranin A in irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD): A shared model for pathogenesis? Inflamm Bowel Dis. 2010;16:361.
- Yen EF, Pardi DS. Review of the microscopic colitis. Curr Gastroenterol Rep. 2011;13:458–462. CrossRef
- Chromogranin A Cell Density as a Diagnostic Marker for Lymphocytic Colitis
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Digestive Diseases and Sciences
Volume 57, Issue 12 , pp 3154-3159
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Chromogranin A
- Computer image analysis
- Lymphocytic colitis
- Industry Sectors
- Author Affiliations
- 1. Section for Gastroenterology, Department of Medicine, Stord Helse-Fonna Hospital, Box 4000, 54 09, Stord, Norway
- 3. Section for Gastroenterology, Institute of Medicine, University of Bergen, Bergen, Norway
- 2. Department of Research, Helse-Fonna, Haugesund, Norway